Insulin aspart, recombinant Subcutaneous and Tedizolid Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Tedizolid Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: tedizolid
Brand name: Sivextro
Synonyms: Tedizolid (oral/injection), Tedizolid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Tedizolid oral/injection
- Insulin aspart, recombinant Subcutaneous-Tedizolid Phosphate
- Insulin aspart, recombinant Subcutaneous-Tedizolid Tablets
- Insulin aspart, recombinant Subcutaneous-Teduglutide
- Insulin aspart, recombinant Subcutaneous-Teduglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Teflaro
- Tedizolid Intravenous-Insulin degludec
- Tedizolid Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Tedizolid Intravenous-Insulin Degludec (U-100) Vials
- Tedizolid Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Tedizolid Intravenous-Insulin degludec and liraglutide
- Tedizolid Intravenous-Insulin degludec and liraglutide Subcutaneous